US2012226354A1PendingUtilityA1
Method of using an implant for treatment of ligaments and tendons
Est. expiryAug 30, 2024(expired)· nominal 20-yr term from priority
A61L 2430/10A61L 27/48A61F 2/0805A61F 2210/0004A61L 27/24A61F 2/08
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of treating a ligament or tendon according to the present invention can include inserting a tissue-generating implant into the ligament or tendon to thereby treat the defect. The tissue-generating implant has a plurality of microparticles. The microparticles subsequently form a biological scaffold which operates at least as partial connective tissue in the ligament or tendon giving structural support during regrowth.
Claims
exact text as granted — not AI-modified1 . A method of treating a ligament or tendon comprising delivering an injectable composition comprising a plurality of inert histocompatible microparticles suspended in a solution containing collagen onto or into the ligament or tendon.
2 . The method of claim 1 , additionally comprising identifying a defect in the ligament or tendon.
3 . The method of claim 1 , wherein the composition forms a biological scaffold comprising at least a portion of the microparticles, and wherein the biological scaffold operates at least as partial connective tissue in the ligament or tendon.
4 . The method of claim 1 , wherein the composition is configured to be partially replaced with host tissue.
5 . (canceled)
6 . The method of claim 1 , wherein the composition comprises at least one of water, saline, a tenside, radiopaque dye, and a chromophobe.
7 . (canceled)
8 . The method of claim 1 , wherein the microparticles are substantially spherical with diameters in the range of about 15 to about 200 microns.
9 . The method of claim 1 , wherein the microparticles comprise one or more of poly methacrylate, polymethylmethacrylate (PMMA), a cured polymer, a fully polymerized polymer, and glass.
10 . The method of claim 1 , wherein the ligament or tendon comprises at least one of an anterior longitudinal ligament, a posterior longitudinal ligament, a supraspinous ligament, an intraspinous ligament, a capsular ligament, an anterior cruciate ligament (ACL), a posterior cruciate ligament (PCL), and a rotator cuff.
11 . The method of claim 2 , wherein a location of the defect is at least one of a musculotendinous junction, a tendinous region, and an insertion of a tendon insertion.
12 . The method of claim 1 , further comprising delivering the composition to an anastomosis site.
13 . The method of claim 1 , further comprising performing tissue treatments on or within the ligament or tendon or adjacent tissue to facilitate tissue reactions.
14 . The method of claim 2 , wherein:
identifying the defect comprises identifying a defect in a patient having congenital, idiopathic, or acquired scoliosis or kyphosis; and delivering the composition comprises delivering the composition to the ligament or tendon in a region of the patient exhibiting abnormal curvature.
15 . The method of claim 14 , further comprising retarding progression of the curvature or partially correcting the curvature.
16 . The method of claim 1 , wherein the composition comprises a chromophobe, the method further comprising activating the chromophobe with a laser to accelerate a reaction in or near the ligament or tendon.
17 . The method of claim 1 , wherein the composition comprises a radiopaque material, the method further comprising visualizing the composition by means of the radiopaque material.
18 . The method of claim 17 , wherein the radiopaque material comprises barium.
19 . (canceled)
20 . (canceled)
21 . A medical kit comprising:
an injectable composition comprising a plurality of inert histocompatible microparticles suspended in a solution containing collagen; and one or more surgical tools configured for repairing at least one tendon or ligament.
22 . The medical kit of claim 21 , further comprising a delivery device configured to deliver the composition.
23 .- 29 . (canceled)
30 . The kit of claim 21 , wherein the microparticles are substantially spherical, and wherein the microparticles have a diameter of about 15 microns to about 200 microns.
31 . The kit of claim 21 , wherein the composition comprises at least one of water, saline, a tenside, radiopaque dye, and a chromophobe.
32 . The kit of claim 21 , wherein the microparticles comprise one or more of poly methacrylate, polymethylmethacrylate (PMMA), a cured polymer, a fully polymerized polymer, and glass.
33 . The kit of claim 21 , wherein the composition comprises a chromophobe for activation with a laser to accelerate a reaction in or near the ligament or tendon.
34 . The kit of claim 21 , wherein the composition comprises a radiopaque material for visualizing the composition by means of the radiopaque material.
35 . The kit of claim 34 , wherein the radiopaque material comprises barium.Join the waitlist — get patent alerts
Track US2012226354A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.